Cbay stock forecast.
According to analyst projections, CBAY’s forecast low is $20.00 with $34.00 as the target high. To hit the forecast high, the stock’s price needs a -82.21% plunge from its current level, while the stock would need to soar -7.18% for it to hit the projected low. Cymabay Therapeutics Inc (CBAY) estimates and forecasts
Dec 1, 2023 · CBAY is a biopharmaceutical company that develops and commercializes new medicines for important human diseases. The stock price, earnings, news, and research reports of CBAY are available on Zacks. See the latest Zacks Rank, Style Scores, EPS Surprise, and more for CBAY. If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.A high-level overview of eBay Inc. (EBAY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.September 8, 2023 at 1:12 PM · 3 min read. Shares of clinical-stage biopharmaceutical company CymaBay Therapeutics, Inc. CBAY gained after it announced positive top-line results from its late ...
Stock Price Forecast The 9 analysts offering 12-month price forecasts for Blink Charging Co have a median target of 5.00, with a high estimate of 25.00 and a low estimate of 3.00.Nov 29, 2023 · Future criteria checks 2/6. CymaBay Therapeutics is forecast to grow earnings and revenue by 47.6% and 61.6% per annum respectively. EPS is expected to grow by 45.7% per annum. Return on equity is forecast to be -57.1% in 3 years.
CymaBay Therapeutics Inc (CBAY) stock is trading at $11.76 as of 11:26 AM on Monday, Jul 3, a rise of $0.81, or 7.39% from the previous closing price of $10.95. The stock has traded between $10.95 and $11.77 so far today. Volume today is low. So far 1,522,720 shares have traded compared to average volume of 2,310,531 shares.
Reported on 11/6/23. Get the latest CymaBay Therapeutics Inc (CBAY) real-time quote, historical performance, charts, and other financial information to help you make more …AC Immune S.A. analyst ratings, historical stock prices, earnings estimates & actuals. ACIU updated stock price target summary.VKTX Stock 12 Months Forecast. $34.00. (187.40% Upside) Based on 6 Wall Street analysts offering 12 month price targets for Viking Therapeutics in the last 3 months. The average price target is $34.00 with a high forecast of $40.00 and a low forecast of $28.00. The average price target represents a 187.40% change from the last price of $11.83.He kept his outperform rating on CBAY stock and raised his price target to 20 from 18. Notably, CymaBay stock has a best-possible Relative Strength Rating of 99, according to IBD Digital. This ...See the latest CymaBay Therapeutics Inc stock price (CBAY:XNAS), related news, valuation, dividends and more to help you make your investing decisions. CBAY Stock Price Quote | Morningstar...
Nov 14, 2023 · CymaBay Therapeutics Stock Forecast 2023. In the last five quarters, CymaBay Therapeutics’s Price Target has fallen from $29.28 to $23.09 - a -21.14% decrease. Five analysts predict that CymaBay Therapeutics’s share price will fall in the coming year, reaching $10.00. This would represent a decrease of -56.69%.
Overview Stock Screener Earnings Calendar Sectors Nasdaq CBAY U.S.: Nasdaq CymaBay Therapeutics Inc. Watch NEW Set a price target alert After Hours Last Updated: Nov 15, 2023 7:49 p.m. EST...
AFIB Stock 12 Months Forecast. $1.62. (184.26% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Acutus Medical in the last 3 months. The average price target is $1.62 with a high forecast of $2.50 and a low forecast of $0.74. The average price target represents a 184.26% change from the last price of $0.57.Based on our forecasts, a long-term increase is expected, the "CBAY" stock price prognosis for 2028-10-27 is 18.476 USD. With a 5-year investment, the revenue is …TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comNov 24, 2023 · Stock analysis for Cymabay Therapeutics Inc (CBAY:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. NextPlay Technologies, Inc. (NASDAQ:NXTP) announced its quarterly earnings results on Wednesday, January, 12th. The company reported ($0.10) earnings per share for the quarter, missing analysts' consensus estimates of ($0.08) by $0.02. The firm earned $4.20 million during the quarter, compared to the consensus estimate of $5.70 …Find the latest Allarity Therapeutics, Inc. (ALLR) stock quote, history, news and other vital information to help you with your stock trading and investing.
Their CBAY share price targets range from $12.00 to $34.00. On average, they expect the company's stock price to reach $22.27 in the next twelve months. This suggests a possible upside of 13.0% from the stock's current price. View analysts price …Title. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result ...CBAY one year fore… Wednesday, November 23, 2022 Edit. emporia hotels in marriott. marriott hotels in emporia va. Quality Inn Emporia November 23, 2022 Edit. Jill Scott wallpaper. ... cbay stock forecast cnn. Based on 5 Wall Street analysts offering 12 month price targets for CymaBay Therapeutics in the last 3 months. CBAY one year …Find real-time ALDX - Aldeyra Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.The current average CBAY price target, as estimated by these analysts, is $0.00. The predictions for the future CBAY stock price range from a low of $0.00 to a high of $0.00, highlighting the variability of market expectations for CBAY.
In the world of business, cash flow is king. Having a clear understanding of your company’s cash flow is essential for making informed financial decisions and ensuring the long-term success of your business.Weather forecasting plays a crucial role in our daily lives, helping us plan our activities and make informed decisions. But have you ever wondered how meteorologists are able to accurately predict the weather? One of the key components in ...
Dec 1, 2023 · CBAY Earnings Date and Information. CymaBay Therapeutics last posted its earnings results on November 7th, 2023. The biopharmaceutical company reported ($0.32) earnings per share for the quarter, missing the consensus estimate of ($0.30) by $0.02. Enhance Your Stock Education with Zacks Research Reports. Each report features independent research from 50 Zacks analysts and details the best of quantitative and qualitative analysis. Once only ...Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.há 4 dias ... For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, ...About the CymaBay Therapeutics, Inc. stock forecast. As of 2023 November 25, Saturday current price of CBAY stock is 19.100$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).. Cymabay Therapeutics stock price as been showing a rising tendency so we believe that similar …UBS has decided to maintain its Buy rating of CymaBay Therapeutics (NASDAQ:CBAY) and raise its price target from $18.00 to $25.00. Shares of CymaBay Therapeutics are trading up 7.26% over the last ...Weather forecasts play an essential role in our daily lives, helping us plan our activities and stay prepared for any weather conditions that may come our way. One of the most common types of forecasts is the 7-day weather forecast, which p...CDTX Stock 12 Months Forecast. Based on 1 Wall Street analysts offering 12 month price targets for Cidara Therapeutics in the last 3 months. The average price target is $6.00 with a high forecast of $6.00 and a low forecast of $6.00. The average price target represents a 679.22% change from the last price of $0.77.3 Wall Street research analysts have issued 1-year price targets for Tecnoglass' shares. Their TGLS share price targets range from $43.00 to $54.00. On average, they anticipate the company's stock price to reach $48.20 in the next year. This suggests a possible upside of 30.2% from the stock's current price.
He kept his outperform rating on CBAY stock and raised his price target to 20 from 18. Notably, CymaBay stock has a best-possible Relative Strength Rating of 99, according to IBD Digital. This ...
CymaBay Therapeutics Inc. (CBAY) stock forecast and price target. Find the latest CymaBay Therapeutics Inc. CBAY analyst stock forecast, price target, and recommendation trends with in-depth ...
Dec 1, 2023 · 6 analysts have issued 12 month price objectives for Spruce Biosciences' shares. Their SPRB share price targets range from $4.00 to $10.00. On average, they expect the company's share price to reach $7.67 in the next year. This suggests a possible upside of 463.7% from the stock's current price. Find the latest Cidara Therapeutics, Inc. (CDTX) stock quote, history, news and other vital information to help you with your stock trading and investing.Sep 8, 2023 · He kept his outperform rating on CBAY stock and raised his price target to 20 from 18. Notably, CymaBay stock has a best-possible Relative Strength Rating of 99, according to IBD Digital. This ... Find the latest CymaBay Therapeutics Inc. CBAY analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. investment rating.Apr 26, 2023 · The stock is selling for $9.87 and its $13.89 average price target suggests a 12-month upside potential of ~41%. (See CBAY stock forecast ) Cerevel Therapeutics ( CERE ) 6 analysts have issued twelve-month price objectives for 89bio's stock. Their ETNB share price targets range from $24.00 to $50.00. On average, they expect the company's stock price to reach $32.89 in the next year. This suggests a possible upside of 315.8% from the stock's current price.CBAY Earnings Date and Information. CymaBay Therapeutics last posted its earnings results on November 7th, 2023. The biopharmaceutical company reported ($0.32) earnings per share for the quarter, missing the consensus estimate of ($0.30) by $0.02.The U.S. National Weather Service (NWS) is a part of the National Oceanic and Atmospheric Administration (NOAA). Many people rely on the National Weather Service’s forecasts in order to better anticipate what the weather will be like so the...Nov 6, 2023 · CBAY Stock Shows Promising Performance: Analysts Predict 38.63% Increase. CBAY stock had a promising performance on November 6, 2023, based on the information provided by CNN Money. The 12 analysts offering 12-month price forecasts for CymaBay Therapeutics Inc have a median target of 22.50, with a high estimate of 33.00 and a low estimate of 19.00. Nov 1, 2021 · For CymaBay Therapeutics stock forecast for 2023, 1 predictions are offered for each month of 2023 with average CymaBay Therapeutics stock forecast of $19.97, a high forecast of $19.97, and a low forecast of $19.97. The average CymaBay Therapeutics stock forecast 2023 represents a 4.58% increase from the last price of $19.1000003814697.
The current CymaBay Therapeutics [ CBAY] share price is $17.90. The Score for CBAY is 74, which is 48% above its historic median score of 50, and infers lower risk than normal. CBAY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels. Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...Stock Price Forecast. The 7 analysts offering 12-month price forecasts for Verastem Inc have a median target of 32.00, with a high estimate of 36.00 and a low estimate of 17.50. The median ...CymaBay Therapeutics Inc. is a biopharmaceutical company. It is focused on the development and commercialization of proprietary new medicines for important human diseases. The Company's lead ...Instagram:https://instagram. erickson inchertz tesla rental pricehow to buy roblox stockfrc stoxk Dec 1, 2023 · Analyst Forecast According to 10 analysts, the average rating for BMEA stock is "Strong Buy." The 12-month stock price forecast is $47.7, which is an increase of 185.97% from the latest price. CymaBay Therapeutics, Inc. is a clinical stage biopharmaceutical company, focused on developing and providing access to therapies for patients with liver and other chronic diseases with high unmet medical need. Its products include MBX-8025 and Arhalofenate, MBX-8025 aims to treat lipid and liver diseases while Arhalofenate intends to reduce ... ats stockhalloween stock Village Farms International Inc () Stock Market info Recommendations: Buy or sell Village Farms International stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Village Farms International share forecasts, stock quote and buy / sell signals below.According to present data Village Farms International's VFF shares and …6 analysts have issued twelve-month price objectives for 89bio's stock. Their ETNB share price targets range from $24.00 to $50.00. On average, they expect the company's stock price to reach $32.89 in the next year. This suggests a possible upside of 315.8% from the stock's current price. pdbc holdings Dec 1, 2023 · Their VKTX share price targets range from $19.00 to $37.00. On average, they predict the company's stock price to reach $30.25 in the next twelve months. This suggests a possible upside of 132.5% from the stock's current price. View analysts price targets for VKTX or view top-rated stocks among Wall Street analysts. The latest CymaBay Therapeutics stock prices, stock quotes, news, and CBAY history to help you invest and trade smarter. ... The 29 analysts offering price forecasts for CymaBay Therapeutics have ...Based on our forecasts, a long-term increase is expected, the "CBAY" stock price prognosis for 2028-10-27 is 18.476 USD. With a 5-year investment, the revenue is …